Jul 23
|
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
|
Jul 22
|
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
|
Jul 22
|
Organon To Report Second Quarter 2025 Results and Host Conference Call on August 5, 2025
|
Jul 21
|
Organon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars
|
Jul 21
|
OGN or MEDP: Which Is the Better Value Stock Right Now?
|
Jul 18
|
Organon (OGN) Registers a Bigger Fall Than the Market: Important Facts to Note
|
Jul 18
|
Unpacking Q1 Earnings: Organon (NYSE:OGN) In The Context Of Other Branded Pharmaceuticals Stocks
|
Jul 15
|
Why Organon (OGN) is Poised to Beat Earnings Estimates Again
|
Jun 27
|
Organon (OGN) Stock Sinks As Market Gains: What You Should Know
|
Jun 26
|
5 Must-Read Analyst Questions From Organon’s Q1 Earnings Call
|
Jun 25
|
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
|
Jun 24
|
Organon (OGN) Outpaces Stock Market Gains: What You Should Know
|
Jun 17
|
All You Need to Know About Organon (OGN) Rating Upgrade to Buy
|
Jun 17
|
OGN or DOCS: Which Is the Better Value Stock Right Now?
|
May 27
|
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection
|
May 9
|
CEO & Director of Organon Picks Up 14% More Stock
|
May 7
|
Organon (NYSE:OGN) Reports Decreased Earnings Affecting Investor Sentiment
|
May 7
|
Organon & Co. (NYSE:OGN) Goes Ex-Dividend Soon
|
May 2
|
Organon price target lowered to $10 from $11 at BofA
|
Apr 2
|
Why Organon (OGN) Could Beat Earnings Estimates Again
|